F. Magnien

发表

Implied risk neutral probability measures on options markets: The L2 approach

A. Trannoy, J. Prigent, F. Magnien, 1996 .

A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.

James S. Scott, B. Barlaam, R. Ducray, 2008, Bioorganic & medicinal chemistry letters.

Discovery of 1-(4-(5-(5-amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl)-1-ethyl-1,2,4-triazol-3-yl)piperidin-1-yl)-3-hydroxypropan-1-one (AZD8835): A potent and selective inhibitor of PI3Kα and PI3Kδ for the treatment of cancers.

S. Green, Rebecca P A Ellston, B. Barlaam, 2015, Bioorganic & medicinal chemistry letters.

Discovery of a novel aminopyrazine series as selective PI3Kα inhibitors.

S. Green, B. Barlaam, S. Cosulich, 2017, Bioorganic & medicinal chemistry letters.

General Equilibrium in Asset Markets with or without Short-Selling

Rose-Anne Dana, Cuong Le Van, R. Dana, 1997 .

Facile preparation and Suzuki–Miyaura cross-coupling of N-2-alkylated 2H-1,2,3-triazole 4-boronates

Paul R. J. Davey, Thomas Tricotet, G. Ouvry, 2012 .

The integration of business statistics into the French national accounts

F. Magnien, 2004 .

GDP Per Capita Measured in Purchasing Power Standard: an Analysis of Results

D. Thesmar, F. Magnien, Jean-Luc Tavernier, 2002 .

On the Different Notions of Arbitrage and Existence of Equilibrium

Rose-Anne Dana, Cuong Le Van, R. Dana, 1999 .